Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies (2019)
- Authors:
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; NORONHA, NÁDIA DE CÁSSIA - FCFRP ; MIZUKAMI, AMANDA - FMRP ; COMINAL, JUÇARA GASTALDI - FCFRP ; ROCHA, JOSÉ LUCAS MARTINS - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1186/s13287-019-1224-y
- Subjects: BIOMATERIAIS; CÉLULAS ESTROMAIS; CITOTOXINAS; FÁRMACOS
- Keywords: Mesenchymal stromal cells; Priming; Cell therapy; Pro-inflammatory cytokines; Pharmaceutical drugs; Biomaterials; Culture conditions
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Stem Cell Research & Therapy
- ISSN: 1757-6512
- Volume/Número/Paginação/Ano: v. 10, n. 1, art. 131, [21] p., 2019
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
NORONHA, Nádia de Cássia et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Research & Therapy, v. 10, n. 1, p. [21] , 2019Tradução . . Disponível em: https://doi.org/10.1186/s13287-019-1224-y. Acesso em: 30 mar. 2026. -
APA
Noronha, N. de C., Mizukami, A., Caliári-Oliveira, C., Cominal, J. G., Rocha, J. L. M., Covas, D. T., et al. (2019). Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Research & Therapy, 10( 1), [21] . doi:10.1186/s13287-019-1224-y -
NLM
Noronha N de C, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Farias KCRM de. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies [Internet]. Stem Cell Research & Therapy. 2019 ; 10( 1): [21] .[citado 2026 mar. 30 ] Available from: https://doi.org/10.1186/s13287-019-1224-y -
Vancouver
Noronha N de C, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Farias KCRM de. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies [Internet]. Stem Cell Research & Therapy. 2019 ; 10( 1): [21] .[citado 2026 mar. 30 ] Available from: https://doi.org/10.1186/s13287-019-1224-y - Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC
- Improving wave-induced motion bioreactor performance for human mesenchymal stromal cell expansion
- CAR-T cells for cancer treatment: current design and next frontiers
- Mesenchymal stromal cells in viral infections: implications for COVID-19
- Platforms for clinical-grade CAR-T cell expansion
- Technologies for large-scale umbilical cord-derived MSC expansion: Experimental performance and cost of goods analysis
- Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
- Production of recombinant coagulation factors:: are humans the best host cells?
- Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells
- A Fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human Mesenchymal stem/stromal cells
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
